This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
TREMFYA® (guselkumab)
Medical Information
TREMFYA - Treatment of Active Psoriatic Arthritis (DISCOVER-1)
Last Updated: 06/13/2025
Summary
A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:
- TREMFYA®
(guselkumab) - Treatment of Active Psoriatic Arthritis (DISCOVER-1) - Minimum requirement to access interactive content: Adobe Acrobat Reader
- The executive summary infographic of the iPDF content is provided below
